Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

37.18
+0.42321.15%
Post-market: 37.11-0.0725-0.20%16:10 EDT
Volume:1K
Turnover:48.43K
Market Cap:17.47M
PE:- -
High:37.49
Open:37.49
Low:37.11
Close:36.75
52wk High:37.90
52wk Low:28.59
Shares:469.95K
Float Shares:469.95K
Volume Ratio:0.59
T/O Rate:0.28%
Dividend:0.41
Dividend Rate:1.10%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Clinical Data Readouts Take Center Stage as Chinese Biotech Firms Surge; CSPC Pharma Climbs Over 4% While Huabao's HK Biotech ETF Holds Key Support

Deep News
·
2 hours ago

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
8 hours ago

Inventiva announces last patient visit in NATiV3 trial

TIPRANKS
·
8 hours ago

Johnson & Johnson to Present at Deutsche Bank 2026 Healthcare Summit

Reuters
·
8 hours ago

Option traders moderately bearish in Eli Lilly with shareslittle changed

TIPRANKS
·
11 hours ago

Sector Update: Healthcare

MT Newswires Live
·
11 hours ago

H.C. Wainwright views Novartis, Alteogen pact as negative for Halozyme

TIPRANKS
·
12 hours ago

Novartis AG Rises Wednesday, Outperforms Market

Dow Jones
·
12 hours ago

Johnson & Johnson's Drug Pipeline Supports Growth Outlook, UBS Securities Says

MT Newswires Live
·
Yesterday

LIVE Markets-Wall Street Starts Slow, Dow Leads

Reuters
·
Yesterday

Johnson & Johnson Stock (JNJ) Opened Up by 3.15% on Sep 2: Key Drivers Unveiled

TradingKey
·
Yesterday

Johnson & Johnson, Boeing Share Gains Contribute to Dow's 250-Point Climb

Dow Jones
·
Yesterday

Aspen Bets on Manufacturing Rebound, Obesity Drug Push for Growth

Reuters
·
Yesterday

Allergan Aesthetics Unveils Layered Beauty Report on Global Shift Toward Personalized Aesthetic Care

Reuters
·
Yesterday

Shenzhen Regulator Launches 2026 Roadshow Selection for Key Medical Device Innovation Projects

Deep News
·
Yesterday

Johnson & Johnson assumed with a Buy at UBS

TIPRANKS
·
Yesterday

Novartis, Alteogen Sign Drug-Technology Deal Worth Up to $3.2 Billion

MT Newswires Live
·
Yesterday

Alteogen enters option, license agreement with Novartis

TIPRANKS
·
Yesterday

Johnson & Johnson : UBS Raises Target Price to $320 from $280

THOMSON REUTERS
·
Yesterday

Novartis Trial Suspensions to Have Limited Financial Impact

Dow Jones
·
Yesterday